AAAAAA
Results:
1-15
|
Results: 15
Authors:
PEACOCK L
HANSEN L
MORKEBERG F
GERLACH J
Citation: L. Peacock et al., CHRONIC DOPAMINE D1, DOPAMINE D2 AND COMBINED DOPAMINE D1 AND D2 ANTAGONIST TREATMENT IN CEBUS-APELLA MONKEYS - ANTIAMPHETAMINE EFFECTS ANDEXTRAPYRAMIDAL SIDE-EFFECTS, Neuropsychopharmacology, 20(1), 1999, pp. 35-43
Authors:
PEACOCK L
CAMPBELL T
PASSARETTI N
RUBENBAUER F
ZAMANIYAN F
MARCHILDON P
Citation: L. Peacock et al., EVALUATION OF COMMERCIAL EIAS FOR DETECTION OF IGG AND IGA ANTIBODIESTO HELICOBACTER-PYLORI, Clinical chemistry, 44, 1998, pp. 24-24
Authors:
YUKSEL U
PEACOCK L
THOMAS H
BLACK K
Citation: U. Yuksel et al., CHARACTERISTICS OF AN EXPERIMENTAL BIOADHESIVE, Thrombosis and haemostasis, 1997, pp. 1020-1020
Authors:
BENESH J
YUKSEL U
PEACOCK L
THOMAS H
MCNALLY R
Citation: J. Benesh et al., PRELIMINARY-RESULTS OF PILOT-STUDIES FOR AN EXPERIMENTAL BIOADHESIVE, Thrombosis and haemostasis, 1997, pp. 1514-1514
Authors:
TIERNEY J
PEACOCK L
SORKIN E
WARE S
Citation: J. Tierney et al., THE PH OF SWEAT OF HORSES - A STUDENT-DEVISED STUDY BY SCIENCE AND HEALTH-SCIENCE MAJORS, Journal of chemical education, 74(9), 1997, pp. 1135-1137
Authors:
KOUIDES P
BURKHART P
PHATAK P
PORTER J
PEACOCK L
BRAGGINS C
COX C
BELLING L
Citation: P. Kouides et al., TYPE-I VON-WILLEBRAND DISEASE CAUSES SIGNIFICANT OBSTETRIC-GYNECOLOGICAL MORBIDITY, Blood, 90(10), 1997, pp. 131-131
Authors:
PEACOCK L
SOLGAARD T
LUBLIN H
GERLACH J
Citation: L. Peacock et al., CLOZAPINE VERSUS TYPICAL ANTIPSYCHOTICS - A RETROSPECTIVE-STUDY AND PROSPECTIVE-STUDY OF EXTRAPYRAMIDAL SIDE-EFFECTS, Psychopharmacology, 124(1-2), 1996, pp. 188-196
Authors:
GERLACH J
LUBLIN H
PEACOCK L
Citation: J. Gerlach et al., EXTRAPYRAMIDAL SYMPTOMS DURING LONG-TERM TREATMENT WITH ANTIPSYCHOTICS - SPECIAL FOCUS ON CLOZAPINE AND D-1 AND D-2 DOPAMINE ANTAGONISTS, Neuropsychopharmacology, 14(3), 1996, pp. 35-39
Authors:
GERLACH J
PEACOCK L
Citation: J. Gerlach et L. Peacock, INTOLERANCE TO NEUROLEPTIC DRUGS - THE ART OF AVOIDING EXTRAPYRAMIDALSYNDROMES, European psychiatry, 10, 1995, pp. 27-31
Authors:
GERLACH J
PEACOCK L
Citation: J. Gerlach et L. Peacock, NEW ANTIPSYCHOTICS - THE PRESENT STATUS, International clinical psychopharmacology, 10, 1995, pp. 39-48
Authors:
VANDENHEUVEL J
LANG V
RICHTER G
PRICE N
PEACOCK L
PROUD C
MCCARTHY JEG
Citation: J. Vandenheuvel et al., THE HIGHLY ACIDIC C-TERMINAL REGION OF THE YEAST INITIATION-FACTOR SUBUNIT 2-ALPHA (EIF-2-ALPHA) CONTAINS CASEIN KINASE PHOSPHORYLATION SITES AND IS ESSENTIAL FOR MAINTAINING NORMAL REGULATION OF GCN4, Biochimica et biophysica acta, N. Gene structure and expression, 1261(3), 1995, pp. 337-348
Authors:
GERLACH J
PEACOCK L
Citation: J. Gerlach et L. Peacock, MOTOR AND MENTAL SIDE-EFFECTS OF CLOZAPINE, The Journal of clinical psychiatry, 55(9), 1994, pp. 107-109
Authors:
PEACOCK L
GERLACH J
Citation: L. Peacock et J. Gerlach, CLOZAPINE TREATMENT IN DENMARK - CONCOMITANT PSYCHOTROPIC MEDICATION AND HEMATOLOGIC MONITORING IN A SYSTEM WITH LIBERAL USAGE PRACTICES, The Journal of clinical psychiatry, 55(2), 1994, pp. 44-49
Authors:
LUBLIN H
GERLACH J
PEACOCK L
Citation: H. Lublin et al., CHRONIC TREATMENT WITH THE D(1) RECEPTOR ANTAGONIST, SCH-23390, AND THE D(2) RECEPTOR ANTAGONIST, RACLOPRIDE, IN CEBUS MONKEYS WITHDRAWN FROM PREVIOUS HALOPERIDOL TREATMENT - EXTRAPYRAMIDAL SYNDROMES AND DOPAMINERGIC SUPERSENSITIVITY, Psychopharmacology, 112(2-3), 1993, pp. 389-397
Authors:
PEACOCK L
GERLACH J
Citation: L. Peacock et J. Gerlach, EFFECTS OF SEVERAL PARTIAL DOPAMINE D2 RECEPTOR AGONISTS IN CEBUS-APELLA MONKEYS PREVIOUSLY TREATED WITH HALOPERIDOL, European journal of pharmacology, 237(2-3), 1993, pp. 329-340
Risultati:
1-15
|